Exploring Updated Data for Large B-Cell Non-Hodgkin Lymphoma
August 5th 2020Nilanjan Ghosh, MD, discusses the significance of the data from a pilot study of lisocabtagene maraleucel in patients ineligible for second-line transplant with relapsed/refractory aggressive large B-cell non-Hodgkin lymphoma.